Clinical Trials Logo

Bradycardia clinical trials

View clinical trials related to Bradycardia.

Filter by:

NCT ID: NCT04738396 Completed - Cardiac Pacing Clinical Trials

Electrogram and Hemodynamic Characteristics of Adaptive LBBAP in Patients With Heart Failure or Bradycardia

Start date: December 29, 2020
Phase:
Study type: Observational

This is a multi-site, non-randomized, data collection study. The purpose of this study is to investigate the cardiac electrical and mechanical function during LBBAP with different AV intervals.

NCT ID: NCT04583709 Completed - Heart Failure Clinical Trials

ECG Belt to Assess Electrical Synchronization

Start date: January 13, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to assess the utility of ECG Belt to understand the conduction and ECG characteristics of Left Bundle Branch Pacing (LBBAP) and His-Optimized Cardiac Resynchronization Therapy (HOT-CRT) and compare with preexisting data in traditional Cardiac Resynchronization Therapy (CRT) and Right Ventricular Pacing (RVP).

NCT ID: NCT04505228 Completed - Clinical trials for Hypertensive Heart Disease

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

Start date: January 20, 2020
Phase: N/A
Study type: Interventional

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

NCT ID: NCT04346537 Completed - Bradycardia Clinical Trials

INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

Start date: August 6, 2020
Phase:
Study type: Observational

The objective of this study is it to confirm the safety and effectiveness of the INGEVITY+ Active Fixation Pace/Sense Lead.

NCT ID: NCT04327466 Completed - Clinical trials for Infant, Premature, Diseases

Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants

Osciflow
Start date: May 22, 2020
Phase: N/A
Study type: Interventional

This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.

NCT ID: NCT04303494 Completed - Clinical trials for Post-immunisation Apnoea and Bradycardia of Prematurity (AOP)

Predictive Value of Heart Rate Variability on Cardiorespiratory Events

Start date: July 1, 2018
Phase:
Study type: Observational

The aim of this study are to investigate whether heart rate variability (HRV) parameters derived from nonlinear time series analysis at five different time points have prognostic utility for assessing the risk of postimmunisation AOP in very preterm/very low birth weight infants immunised in the hospital.

NCT ID: NCT04198220 Completed - Atrial Fibrillation Clinical Trials

BIO|STREAM.ICM Obesity

Start date: September 17, 2020
Phase:
Study type: Observational

The aim of the submodule study is to assess whether a high BMI may influence the sensing performance and the sECG quality of the BIOMONITOR.

NCT ID: NCT04184245 Completed - Preterm Birth Clinical Trials

Hemodynamic Responses to Cardio-respiratory Events in Preterm Infants

Start date: February 22, 2018
Phase:
Study type: Observational

Intermittent episodes of hypoxemia and/or bradycardia, also defined as cardio-respiratory events (CRE) are very frequent in preterm infants and may result in transient hypoxia and hypoperfusion of target organs, with possible clinical implications. The hemodynamic instability that characterizes the first 72 hours of life, also called as transitional period, place preterm infants at high risk of complications and may contribute to enhance fluctuations in end-organ perfusion and oxygenation induced by CRE. In this study we aimed to explore cardiovascular and cerebrovascular changes determined by different CRE types in preterm infants during the transitional period.

NCT ID: NCT04123691 Completed - Premature Birth Clinical Trials

Cardio-respiratory Events in Preterm Infants During Transition

Start date: February 21, 2018
Phase:
Study type: Observational

Cardio-respiratory events (CRE), defined as intermittent episodes of hypoxemia and/or bradycardia, are particularly common among preterm infants. It has been previously shown that CRE result in transient brain hypoxia and hypoperfusion and may represent a possible risk factor for neurodevelopmental impairment and retinopathy of prematurity. The high cardio-respiratory instability typically seen in preterm infants during the first 72 hours of life may influence CRE occurrence, with possible clinical implications. This study aims to characterize CRE features in this transitional period and to evaluate whether specific neonatal and clinical characteristics are associated with different CRE types. Newborn infants with gestational age (GA) <32 weeks or birth weight (BW) <1500 g are enrolled. Congenital malformations and mechanical ventilation are exclusion criteria. During the first 72 hours, heart rate (HR) and peripheral oxygen saturation (SpO2) are continuously monitored, and an echocardiogram is performed to assess the status of the ductus arteriosus. CRE are clustered into isolated desaturation (ID, SpO2<85%), isolated bradycardia (IB, HR<100 bpm or <70% baseline), combined desaturation and bradycardia (DB, occurrence of the two events within a 60-sec window). According to their duration and SpO2 and/or HR nadir values, CRE are also classified as mild (SpO2 80-84% and HR 80-100 bpm and duration <60 sec), moderate (SpO2 70-79% or HR 80-60 bpm or duration 61-120 sec) or severe (SpO2 <70% or HR <60 bpm or duration >120 sec). A generalized estimating equation (GEE) will be used to examine the impact of relevant variables on CRE type and severity.

NCT ID: NCT04069078 Completed - Clinical trials for Cesarean Section Complications

Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section

Start date: October 10, 2019
Phase: Phase 4
Study type: Interventional

The aim of this study is to assess the efficacy of Iv hyoscine butylbromide in preventing Bradycardia during cesarean section under spinal anaesthesia with local anaesthetic and morphine.